Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 24, 2023

BUY
$49.7 - $57.71 $437,161 - $507,617
8,796 Added 1370.09%
9,438 $481,000
Q3 2022

Nov 15, 2022

SELL
$53.86 - $66.8 $65,655 - $81,429
-1,219 Reduced 65.5%
642 $35,000
Q2 2022

Aug 16, 2022

SELL
$63.83 - $80.0 $14,106 - $17,680
-221 Reduced 10.61%
1,861 $119,000
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $160,001 - $186,234
2,082 New
2,082 $162,000
Q4 2021

Feb 15, 2022

SELL
$74.57 - $87.19 $242,277 - $283,280
-3,249 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$73.77 - $83.61 $446,160 - $505,673
-6,048 Reduced 65.05%
3,249 $280,000
Q2 2021

Aug 16, 2021

BUY
$80.5 - $88.01 $748,408 - $818,228
9,297 New
9,297 $748,000
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $607,869 - $664,068
-8,063 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$78.33 - $90.73 $631,574 - $731,555
8,063 New
8,063 $648,000
Q2 2020

Aug 17, 2020

SELL
$78.66 - $94.14 $255,566 - $305,860
-3,249 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$78.66 - $94.14 $149,139 - $178,489
1,896 Added 140.13%
3,249 $280,000
Q1 2020

May 15, 2020

BUY
$71.57 - $93.3 $96,834 - $126,234
1,353 New
1,353 $110,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.